It was reported that the estimated battery longevity for the cardiac resynchronization therapy defibrillator (crt-d) decreased from two years remaining to elective replacement indicator (eri) within three months' time frame.Technical services (ts) was contacted to review the data.Upon review, ts determined the power consumption of the device has been stable and the voltage was decreasing as expected.Engineering analysis determined the device was depleting normally.A deeper analysis of the data was performed due to the decrease in longevity within the short time frame.Review of that data determined the rate of depletion is normal, however the charge time began to increase earlier than expected.Eri was set due to two charges in excess of 15 seconds.The charge time increase was unanticipated and eri was set early than expected.Engineering confirmed that although eri declaration was shorter than expected, the longevity of the crt-d is still within the expected time frame as the device lasted 8.9 years from implant to eri.Ts discussed that normal change out time frame post eri declaration is acceptable.At this time the crt-d remains in service and no adverse effects were reported.
|